Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 71335-2362

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 71335-2362). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352362)

Label for Olmesartan Medoxomil Tablets USP 40 mg, film-coated tablets supplied in a unit-dose package of 30 tablets. The label includes storage instructions and a caution that the package is not child-resistant. It indicates the product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Aurobindo Pharma Limited. The label shows NDC 71335-2362-1.*

FDA Label Image

Olmesartan Medoxomil Dose Response Placebo-adjusted Reduction In Blood Pressure (mmhg) (Olmesartan Fig1)

A dose-response line graph showing placebo-adjusted reduction in blood pressure (mmHg) for Olmesartan Medoxomil tablets. The x-axis presents Olmesartan Medoxomil dose in mg (0 to 100), and the y-axis shows reduction in blood pressure (mmHg) from 0 to 14. Two lines represent systolic and diastolic blood pressure reductions across increasing doses, with systolic reduction exceeding diastolic reduction at all doses.*

FDA Label Image

Chemical Structure (Olmesartan Str)

Chemical structure diagram of Olmesartan Medoxomil, depicting its molecular arrangement with labeled atoms and bonds consistent with its chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.